|
Apr 23
|
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
|
|
Apr 22
|
25 Richest Billionaires in Healthcare Industry
|
|
Apr 22
|
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
|
|
Apr 7
|
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
|
|
Mar 31
|
The 3 Best Bargain Stocks to Buy in Q2 2024
|
|
Mar 26
|
3 Biotech Stocks to Buy for the Next Bull Run: March 2024
|
|
Mar 26
|
This Vaccine Maker Sits on Cash Almost Equal to Its Market Value
|
|
Mar 25
|
UPDATE 2-BioNTech gets US agency notice over default on COVID vaccine royalties
|
|
Mar 24
|
BioNTech Full Year 2023 Earnings: Misses Expectations
|
|
Mar 23
|
Earnings Miss: BioNTech SE Missed EPS By 14% And Analysts Are Revising Their Forecasts
|
|
Mar 21
|
BioNTech SE (NASDAQ:BNTX) Q4 2023 Earnings Call Transcript
|
|
Mar 21
|
Q4 2023 BioNTech SE Earnings Call
|
|
Mar 20
|
BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts
|
|
Mar 20
|
BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials
|
|
Mar 20
|
BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript
|
|
Mar 20
|
BioNTech expects more than 10 bln eur peak sales from cancer drug pipeline
|
|
Mar 20
|
BioNTech Earnings Miss Estimates. The Stock Falls and Also Drags Moderna Lower.
|
|
Mar 20
|
UPDATE 1-After earnings plunge, BioNTech pins hopes on cancer drug launches
|
|
Mar 20
|
BioNTech slides as earnings plunge amid cancer drug shift
|
|
Mar 20
|
After earnings plunge, BioNTech pins hopes on cancer drug launches
|